MarketCap
Calliditas Therapeutics AB (publ) CALT
Facebook
X
Telegram
Land |
 Schweden |
IPO-Jahr |
2020 |
Branche |
Arzneimittelhersteller |
Börse |
NASDAQ GLOBAL |
Anteile |
53.7 M |
Marktkapitalisierung |
$ 2.03 B |
EBITDA (LTM) |
$ -902 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-19.06 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market |  USA |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE |  Canada |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.16 | 0.42 % | $ 111 M | Nasdaq Global Select Market | Canada |
 |
Sundial Growers
SNDL
|
$ 1.44 | 1.77 % | $ 372 M | Nasdaq Global Select Market | Canada |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Perrigo Company plc
PRGO
|
$ 14.92 | 4.56 % | $ 2.07 B | NYSE | USA |
 |
Canopy Growth Corporation
CGC
|
$ 0.97 | 0.17 % | $ 289 M | Nasdaq Global Select Market | Canada |
 |
Aurora Cannabis
ACB
|
$ 3.95 | 1.54 % | $ 217 M | NYSE | Canada |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Assertio Holdings
ASRT
|
- | - | $ 150 M | Nasdaq Capital Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Bausch Health Companies
BHC
|
$ 6.56 | 5.56 % | $ 2.43 B | NYSE | Canada |
 |
China Pharma Holdings
CPHI
|
$ 0.82 | 0.1 % | $ 3.52 M | NYSE American |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 6.79 | 0.59 % | $ 101 M | Nasdaq Global Select Market | USA |
 |
Cronos Group
CRON
|
$ 3.26 | 0.62 % | $ 1.25 B | Nasdaq Global Market | Canada |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Emergent BioSolutions
EBS
|
$ 6.21 | 0.08 % | $ 332 M | NYSE,SPB | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Evolus
EOLS
|
$ 9.3 | 2.76 % | $ 600 M | Nasdaq Global Market | USA |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Harrow Health
HROW
|
$ 38.54 | 0.73 % | $ 1.42 B | Nasdaq Global Market | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Organogenesis Holdings
ORGO
|
$ 1.71 | 4.27 % | $ 217 M | Nasdaq Capital Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 26.35 | 0.08 % | $ 1.17 B | Nasdaq Global Select Market,SPB | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.43 | 1.37 % | $ 175 M | Nasdaq Global Select Market,SPB | USA |
 |
Rockwell Medical
RMTI
|
$ 7.99 | 1.31 % | $ 287 M | Nasdaq Global Market | USA |
 |
SCYNEXIS
SCYX
|
$ 5.3 | 0.47 % | $ 265 M | Nasdaq Global Select Market | USA |
 |
Solid Biosciences
SLDB
|
$ 10.25 | 1.31 % | $ 897 M | Nasdaq Global Select Market,SPB | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 1.33 | 0.38 % | $ 2.24 M | Nasdaq Capital Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Tilray
TLRY
|
$ 4.5 | 0.22 % | $ 4.01 B | Nasdaq Global Select Market | Canada |
 |
TherapeuticsMD
TXMD
|
$ 2.21 | 0.22 % | $ 25.6 M | Nasdaq Global Select Market | USA |
 |
Veru
VERU
|
$ 2.64 | 0.94 % | $ 38.7 M | Nasdaq Capital Market | USA |
 |
Viatris
VTRS
|
$ 16.88 | 0.03 % | $ 19.4 B | Nasdaq Global Select Market,SPB | USA |
 |
cbdMD
YCBD
|
$ 0.5 | 4.68 % | $ 2.01 M | NYSE American | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |